InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-0.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by YOUNG JOHN D, Chief Executive Officer. Director active across 3 companies, notably PFIZER INC. In total, 11 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €122k. Activity tracked since 7 May 2021. The latest transaction was filed on 25 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
16,025 shares0Common StockSEC:0001655759-25-000120:0
2,287 shares0Ordinary SharesSEC:0001127602-25-009417:0
5,899 shares0Common StockSEC:0001655759-24-000082:0
2,889 shares0Ordinary SharesSEC:0001127602-24-010201:0
1,401 shares@ US$61.7348.9% of flowOrdinary SharesSEC:0001127602-24-009435:0
4,121 shares0Common StockSEC:0001655759-23-000068:0
2,843 shares0Ordinary SharesSEC:0001127602-23-009841:0
1,372 shares@ US$63.4651.1% of flowOrdinary SharesSEC:0001127602-23-009648:0
2,786 shares0Ordinary SharesSEC:0001127602-22-008979:0
2,800 shares@ US$50.160.0001% mcap50.0% of flowCommon StockSEC:0001225208-21-013850:0
8,830 shares0Common StockSEC:0001225208-21-008216:0
11 of 11 declarations
About YOUNG JOHN D
John D. Young is the Group President and CEO at Pfizer Inc and Johnson Controls International plc. He oversees the operations and strategy of both companies, playing a key role in their growth and innovation. His leadership is essential for maintaining market leadership.
